Daptomycin 70594-0060
Product NDC
70594-0060- Manufacturer
- Xellia Pharmaceuticals Usa Llc
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- November 3, 2023
- Listing Expires
- December 31, 2026
- Application
- NDA217415
Need to source Daptomycin? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Daptomycin | 500 mg/10mL |
Drug Class
Lipopeptide Antibacterial [EPC]Lipopeptide Antibacterial [EPC]Lipopeptides [CS]
Packaging Options(1)
1 VIAL, SINGLE-USE in 1 CARTON (70594-060-01) / 10 mL in 1 VIAL, SINGLE-USE